secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001628280-25-037048
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Sanuwave Health enters separation agreement with former CCO Nanci Gilmore
-------------------------------------------------------------------------

- Nanci Gilmore, former Chief Commercial Officer, was terminated without cause effective May 30, 2025.
- Separation agreement provides lump sum cash of $97,916.70 (5 months salary) and pro-rated bonus of $14,790.81.
- Stock options continue vesting through Jan 31, 2026: 31,111 options vest in three tranches (6,222; 6,223; 6,222).
- Vested options remain exercisable at $14.20 per share until their original expiration dates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025037048/0001628280-25-037048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025037048/snwv-20250728.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-037048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer